MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Etiology and Pathogenesis"

  • 2019 International Congress

    Acute Onset Parkinsonism Secondary to West Nile Virus Encephalitis

    M. Purbaugh, F. Ali, T. Diesing, A. Hellman (Omaha, NE, USA)

    Objective: To demonstrate a case of acute Parkinsonism caused by West Nile Virus (WNV) Encephalitis that improved with resolution of the infection. Background: Acute onset…
  • 2019 International Congress

    Regardless of impaired renal function, negative myoclonus can be induced by gabapetin and pregabalin

    DY. Kwon, MH. Park (Gyenggi-Do, Republic of Korea)

    Objective: This study evaluated pregabalin- or gabapentin-induced negative myoclonus according to renal function. Background: Gabapentin and pregabalin are commonly used to control neuropathic pain and epilepsy.…
  • 2019 International Congress

    Drug-induced Negative Myoclonus: A Case Report

    L. Lerjefors, M. Mainardi, A. Antonini, M. Carecchio (Padova, Italy)

    Objective: To report on a case of drug-induced negative myoclonus in a patient with a complex oral therapy. Background: Myoclonus is a shock-like jerk due…
  • 2019 International Congress

    Adult-Onset Parainfectious Opsoclonus-Myoclonus: Report of Two Cases

    MI. Gaston, I. Rubio, J. Muruzabal, R. Larumbe, M. Martin, L. Martinez (Pamplona, Spain)

    Objective: Present two cases of Adult-Onset parainfectious Opsoclonus-Myoclonus Syndrome with fast and good recovery Background: Adult-Onset Opsoclonus-Myoclonus  (AOMS) is a rare disorder. Two main causes…
  • 2019 International Congress

    Steroid-responsive myoclonus in the context of pembrolizumab treatment: a novel neurological phenotype.

    M. Murphy, S. O'Dowd, M. Alexander (Dublin, Ireland)

    Objective: To outline a novel immunologically-mediated neurological adverse event associated with the use of a medication class which has an expanding range of applications [1].…
  • 2019 International Congress

    High dose amantadine therapy may cause increased falling in Parkinson’s patients

    L. Verhagen Metman (Chicago, IL, USA)

    Objective: To report a possible association between high dose amantadine and increased falling in patients with Parkinson’s disease (PD). Background: Amantadine is used in PD…
  • 2019 International Congress

    A retrospective analysis of clinical and electrophysiological characteristics of patients with myoclonus

    A. Gunduz, M. E. Kızıltan, H. Ser, N. Yeni, C. Ozkara, V. Demirbilek, C. Yalçınkaya, G. Kızıltan (Istanbul, Turkey)

    Objective: We aimed to evaluate the clinical characteristics of patients with myoclonus and to identify the possible etiologies in different types of myoclonus based on…
  • 2019 International Congress

    Generalised Polymyoclonus In a Patient With Central Nervous System Tuberculosis

    K. Shahedah, MS. Mohamad Salmi (Pahang, Malaysia)

    Objective: Myoclonus associated with tuberculosis or following an infectious event is a transient event with an abrupt onset. It is a rare phenomenon and often…
  • 2019 International Congress

    Dancing larynx syndrome associated with trigeminal neuralgia secondary to multiple sclerosis

    D. Shpiner, M. Ortega, H. Moore (Miami, FL, USA)

    Objective: To describe a rare a case of a patient who developed “dancing larynx”-like syndrome after gamma knife radiation for trigeminal neuralgia (TN) associated with…
  • 2018 International Congress

    Tardive Myoclonus: A Case Report

    S. Gazioglu, F. Civil Arslan, V. Altunayoglu Cakmak, M. Korucuk, M. Ozmenoglu (Trabzon, Turkey)

    Objective: To report a patient with late-onset myoclonus after treatment with antipsychotic drugs which is a rare variant of tardive movement disorders. Background: The use…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley